StonvexLoading…
StonvexStonvexStonvexCore line items from LNZA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $12.02M | $55.84M | $27.85M | $18.57M |
Operating Income | $-9.81M | $-79.16M | $-78.95M | $-63.29M |
Net Income | $-14.68M | $-48.95M | $-48.87M | $-32.50M |
EPS (Diluted) | $-1.77 | $-22.27 | $-22.66 | $-0.25 |
Total Assets | $105.21M | $100.21M | $99.29M | $116.30M |
Total Liabilities | $57.15M | $90.93M | $91.10M | $128.31M |
Cash & Equivalents | $19.86M | $13.16M | $19.63M | $37.37M |
Free Cash Flow OCF − CapEx | $-9.32M | $-66.11M | $-59.74M | $-43.69M |
Shares Outstanding | 10.09M | 2.32M | 2.32M | 232.00M |